Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
46
datasets available to search
ShareScore release 0.9.0
Dataset results
46 results for “Prostate-specific antigen”
Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer
GEO Series GSE211452. Homo sapiens. 28 samples. Type: Expression profiling by high throughput sequencing; Genome binding/occupancy profiling by high throughput sequencing.
Extended Study of Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer
ClinicalTrials.gov study NCT01414296. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trans and Non-binary Prostate-Specific Antigen Reference Interval Determination Study
ClinicalTrials.gov study NCT06987045. IPD Sharing: NO. Countries: 0. Publications: 0.
Effects of Alpha Blockers on Prostate-specific Antigen (PSA) Change in Men With Lower Urinary Tract Symptoms (LUTS)
ClinicalTrials.gov study NCT01250483. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Correlation Between Prostate-specific Membrane Antigen Positron Emission Tomography and Arterial Spin Labeling Perfusion Imaging in Glioblastoma
ClinicalTrials.gov study NCT06600399. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Predictive Value of Prostate-specific Antigen Isoform p2psa and Its Derivates in the Diagnosis of Prostate Cancer
ClinicalTrials.gov study NCT01672411. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer
ClinicalTrials.gov study NCT01414283. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Evaluation of [177Lu]Lu-BQ7876 for Targeting of Prostate-Specific Membrane Antigen
ClinicalTrials.gov study NCT06641219. IPD Sharing: YES. Countries: 1. Publications: 0.
Soy Protein Supplement in Preventing Prostate Cancer in Patients With Elevated Prostate-Specific Antigen Levels
ClinicalTrials.gov study NCT00031746. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test
ClinicalTrials.gov study NCT05629494. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of Prostate-Specific Antigen (PSA) Levels in Patients With Advanced Prostate Cancer Treated With Bicalutamide
ClinicalTrials.gov study NCT00871585. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Screening for Prostate Cancer Among Those Prostate-specific Antigen Value Between 2.5 and 4.0 ng/mL
ClinicalTrials.gov study NCT04317625. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Soy Isoflavones in Treating Patients With Recurrent Prostate Cancer or Rising Prostate-Specific Antigen
ClinicalTrials.gov study NCT01682941. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Frequency of Prostate-Specific Antigen Screening in African American Men in the San Francisco Area
ClinicalTrials.gov study NCT00702104. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy
ClinicalTrials.gov study NCT05995236. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Combined Prostate-specific Antigen, Multi-parametric MRI and Targeted Prostate Biopsy for Prostate Cancer Screening
ClinicalTrials.gov study NCT04322045. IPD Sharing: NO. Countries: 1. Publications: 0.
Determination of Prostate-specific Antigen in Capillary Blood (PSA-Cap)
ClinicalTrials.gov study NCT06626386. IPD Sharing: NO. Countries: 1. Publications: 0.
Molecular Imaging of Prostate-Specific Membrane Antigen Using Labeled Technetium-99m BQ0413
ClinicalTrials.gov study NCT06101927. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Risk-adapted Strategy Including Magnetic Resonance Imaging and Prostate-specific Antigen Density in Blood for Biopsy Decision in Patients With Lesions Suspicious for Prostate Cancer
ClinicalTrials.gov study NCT06029088. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2 Trial of Darolutamide as a Prostate-Specific Membrane Antigen (PSMA) Expression Enhancer in Patients With Localized Prostate Cancer
ClinicalTrials.gov study NCT05900973. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.